THE TRANSFORMER

Tirzepatide

Grade A — Excellent

The ultimate FDA-approved weight loss solution—lose 20%+ of your body weight.

Also known as: Mounjaro, LY3298176

Metabolic Modulator
Weight Management
Cardiovascular Support
Appetite & Metabolic Control

Overview

Tirzepatide is a breakthrough dual-action peptide that activates both GLP-1 and GIP receptors - two key hormones that control blood sugar and appetite. It's the most effective weight loss medication available, helping people lose 20%+ of their body weight in clinical trials. It also dramatically improves blood sugar control and may protect your heart. FDA-approved as Mounjaro.

Key Benefits & Mechanisms

Dual Incretin Action

Activates both GLP-1 and GIP receptors for enhanced metabolic effects

Appetite Center Modulation

Stimulates satiety neurons (POMC) and inhibits hunger neurons (AgRP/NPY)

Insulin Enhancement

Increases glucose-dependent insulin secretion while suppressing glucagon

Gastric Slowing

Delays stomach emptying to prolong feelings of fullness

Dosing Guide

Dosage

2.5 mg weekly, titrating up every 4 weeks

Schedule

weekly

Cycle

12-24 weeks per treatment cycle

Pro Tip

Start at 2.5 mg and increase slowly (every 4 weeks) to minimize GI side effects. Take at the same time each week.

This peptide requires titration — start with a lower dose and increase gradually.

Safety Profile

A

Excellent Safety

Excellent

FDA-approved with extensive clinical trial data. Well-characterized side effect profile.

Common GI side effects typically improve over 4-8 weeks. Titrate slowly to minimize nausea. Not for Type 1 diabetes.

Possible Side Effects

Nausea
Vomiting
Diarrhea
Reduced appetite
Constipation
Indigestion
Injection site reactions

What to Expect

Week 1

Noticeable appetite reduction, possible nausea

Week 4-8

Significant weight loss begins, blood sugar improves

Week 12-16

10-15% body weight loss, GI side effects typically resolve

Week 24+

20%+ weight loss possible, sustained metabolic improvements

Appetite reduction within first week. Significant weight loss typically begins by week 4-8.

Who Is This For

People struggling with obesity or significant weight loss goals
Those with Type 2 diabetes needing better blood sugar control
Anyone who has plateaued with other weight loss methods
People wanting cardiovascular protection alongside weight loss
Those who prefer weekly injections over daily medications

Research References

[1]SURMOUNT Trial Results - Tirzepatide for Weight Loss[2]FDA Mounjaro Prescribing Information

Related Peptides

Tesofensine

C

THE APPETITE CRUSHER

Powerful appetite control through brain chemistry

TB-500

B

THE REGENERATOR

Promotes new blood vessel growth and reduces inflammation for stubborn injuries.

ACE-031

C

THE MUSCLE UNLEASHED

Block the muscle-limiting signal and unlock serious gains

BAM-15

B

THE CALORIE BURNER

Make your cells burn more fuel - mitochondrial uncoupling for fat loss

Cardiogen

A

THE CARDIAC REGENERATOR

Four-amino-acid peptide for heart repair and regeneration

Hexarelin

B

THE HEART STRENGTHENER

The strongest GHRP with unique heart-protective benefits

Ready to Start Your Peptide Journey?

Track your protocols, get guided reconstitution, and access our vetted vendor network — all in one app.

Download The Peptide App